Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Family Floater Health Insurance Market

ID: MRFR/BS/22510-HCR
128 Pages
Nirmit Biswas
Last Updated: April 24, 2026

Family Floater Health Insurance Market Size, Share and Research Report By Premium Range (Low Premium, Mid Premium, High Premium), By Plan Type (Comprehensive Plan, Specific Illness Plan, Critical Illness Plan), By Sum Assured (Up to Rs. 5 lakhs, Rs. 5 lakhs to Rs. 10 lakhs, Above Rs. 10 lakhs), By Rider Options (Maternity Rider, Child Rider, Hospital Cash Rider) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Industry Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Family Floater Health Insurance Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 BFSI, BY Premium Range (USD Billion)
  49.     4.1.1 Low Premium
  50.     4.1.2 Mid Premium
  51.     4.1.3 High Premium
  52.   4.2 BFSI, BY Plan Type (USD Billion)
  53.     4.2.1 Comprehensive Plan
  54.     4.2.2 Specific Illness Plan
  55.     4.2.3 Critical Illness Plan
  56.   4.3 BFSI, BY Sum Assured (USD Billion)
  57.     4.3.1 Up to Rs. 5 lakhs
  58.     4.3.2 Rs. 5 lakhs to Rs. 10 lakhs
  59.     4.3.3 Above Rs. 10 lakhs
  60.   4.4 BFSI, BY Rider Options (USD Billion)
  61.     4.4.1 Maternity Rider
  62.     4.4.2 Child Rider
  63.     4.4.3 Hospital Cash Rider
  64.   4.5 BFSI, BY Region (USD Billion)
  65.     4.5.1 North America
  66.       4.5.1.1 US
  67.       4.5.1.2 Canada
  68.     4.5.2 Europe
  69.       4.5.2.1 Germany
  70.       4.5.2.2 UK
  71.       4.5.2.3 France
  72.       4.5.2.4 Russia
  73.       4.5.2.5 Italy
  74.       4.5.2.6 Spain
  75.       4.5.2.7 Rest of Europe
  76.     4.5.3 APAC
  77.       4.5.3.1 China
  78.       4.5.3.2 India
  79.       4.5.3.3 Japan
  80.       4.5.3.4 South Korea
  81.       4.5.3.5 Malaysia
  82.       4.5.3.6 Thailand
  83.       4.5.3.7 Indonesia
  84.       4.5.3.8 Rest of APAC
  85.     4.5.4 South America
  86.       4.5.4.1 Brazil
  87.       4.5.4.2 Mexico
  88.       4.5.4.3 Argentina
  89.       4.5.4.4 Rest of South America
  90.     4.5.5 MEA
  91.       4.5.5.1 GCC Countries
  92.       4.5.5.2 South Africa
  93.       4.5.5.3 Rest of MEA
  94. 5 SECTION V: COMPETITIVE ANALYSIS
  95.   5.1 Competitive Landscape
  96.     5.1.1 Overview
  97.     5.1.2 Competitive Analysis
  98.     5.1.3 Market share Analysis
  99.     5.1.4 Major Growth Strategy in the BFSI
  100.     5.1.5 Competitive Benchmarking
  101.     5.1.6 Leading Players in Terms of Number of Developments in the BFSI
  102.     5.1.7 Key developments and growth strategies
  103.       5.1.7.1 New Product Launch/Service Deployment
  104.       5.1.7.2 Merger & Acquisitions
  105.       5.1.7.3 Joint Ventures
  106.     5.1.8 Major Players Financial Matrix
  107.       5.1.8.1 Sales and Operating Income
  108.       5.1.8.2 Major Players R&D Expenditure. 2023
  109.   5.2 Company Profiles
  110.     5.2.1 UnitedHealth Group (US)
  111.       5.2.1.1 Financial Overview
  112.       5.2.1.2 Products Offered
  113.       5.2.1.3 Key Developments
  114.       5.2.1.4 SWOT Analysis
  115.       5.2.1.5 Key Strategies
  116.     5.2.2 Anthem (US)
  117.       5.2.2.1 Financial Overview
  118.       5.2.2.2 Products Offered
  119.       5.2.2.3 Key Developments
  120.       5.2.2.4 SWOT Analysis
  121.       5.2.2.5 Key Strategies
  122.     5.2.3 Aetna (US)
  123.       5.2.3.1 Financial Overview
  124.       5.2.3.2 Products Offered
  125.       5.2.3.3 Key Developments
  126.       5.2.3.4 SWOT Analysis
  127.       5.2.3.5 Key Strategies
  128.     5.2.4 Cigna (US)
  129.       5.2.4.1 Financial Overview
  130.       5.2.4.2 Products Offered
  131.       5.2.4.3 Key Developments
  132.       5.2.4.4 SWOT Analysis
  133.       5.2.4.5 Key Strategies
  134.     5.2.5 Humana (US)
  135.       5.2.5.1 Financial Overview
  136.       5.2.5.2 Products Offered
  137.       5.2.5.3 Key Developments
  138.       5.2.5.4 SWOT Analysis
  139.       5.2.5.5 Key Strategies
  140.     5.2.6 Bupa (GB)
  141.       5.2.6.1 Financial Overview
  142.       5.2.6.2 Products Offered
  143.       5.2.6.3 Key Developments
  144.       5.2.6.4 SWOT Analysis
  145.       5.2.6.5 Key Strategies
  146.     5.2.7 Allianz (DE)
  147.       5.2.7.1 Financial Overview
  148.       5.2.7.2 Products Offered
  149.       5.2.7.3 Key Developments
  150.       5.2.7.4 SWOT Analysis
  151.       5.2.7.5 Key Strategies
  152.     5.2.8 AXA (FR)
  153.       5.2.8.1 Financial Overview
  154.       5.2.8.2 Products Offered
  155.       5.2.8.3 Key Developments
  156.       5.2.8.4 SWOT Analysis
  157.       5.2.8.5 Key Strategies
  158.     5.2.9 State Farm (US)
  159.       5.2.9.1 Financial Overview
  160.       5.2.9.2 Products Offered
  161.       5.2.9.3 Key Developments
  162.       5.2.9.4 SWOT Analysis
  163.       5.2.9.5 Key Strategies
  164.     5.2.10 MetLife (US)
  165.       5.2.10.1 Financial Overview
  166.       5.2.10.2 Products Offered
  167.       5.2.10.3 Key Developments
  168.       5.2.10.4 SWOT Analysis
  169.       5.2.10.5 Key Strategies
  170.   5.3 Appendix
  171.     5.3.1 References
  172.     5.3.2 Related Reports
  173. 6 LIST OF FIGURES
  174.   6.1 MARKET SYNOPSIS
  175.   6.2 NORTH AMERICA MARKET ANALYSIS
  176.   6.3 US MARKET ANALYSIS BY PREMIUM RANGE
  177.   6.4 US MARKET ANALYSIS BY PLAN TYPE
  178.   6.5 US MARKET ANALYSIS BY SUM ASSURED
  179.   6.6 US MARKET ANALYSIS BY RIDER OPTIONS
  180.   6.7 CANADA MARKET ANALYSIS BY PREMIUM RANGE
  181.   6.8 CANADA MARKET ANALYSIS BY PLAN TYPE
  182.   6.9 CANADA MARKET ANALYSIS BY SUM ASSURED
  183.   6.10 CANADA MARKET ANALYSIS BY RIDER OPTIONS
  184.   6.11 EUROPE MARKET ANALYSIS
  185.   6.12 GERMANY MARKET ANALYSIS BY PREMIUM RANGE
  186.   6.13 GERMANY MARKET ANALYSIS BY PLAN TYPE
  187.   6.14 GERMANY MARKET ANALYSIS BY SUM ASSURED
  188.   6.15 GERMANY MARKET ANALYSIS BY RIDER OPTIONS
  189.   6.16 UK MARKET ANALYSIS BY PREMIUM RANGE
  190.   6.17 UK MARKET ANALYSIS BY PLAN TYPE
  191.   6.18 UK MARKET ANALYSIS BY SUM ASSURED
  192.   6.19 UK MARKET ANALYSIS BY RIDER OPTIONS
  193.   6.20 FRANCE MARKET ANALYSIS BY PREMIUM RANGE
  194.   6.21 FRANCE MARKET ANALYSIS BY PLAN TYPE
  195.   6.22 FRANCE MARKET ANALYSIS BY SUM ASSURED
  196.   6.23 FRANCE MARKET ANALYSIS BY RIDER OPTIONS
  197.   6.24 RUSSIA MARKET ANALYSIS BY PREMIUM RANGE
  198.   6.25 RUSSIA MARKET ANALYSIS BY PLAN TYPE
  199.   6.26 RUSSIA MARKET ANALYSIS BY SUM ASSURED
  200.   6.27 RUSSIA MARKET ANALYSIS BY RIDER OPTIONS
  201.   6.28 ITALY MARKET ANALYSIS BY PREMIUM RANGE
  202.   6.29 ITALY MARKET ANALYSIS BY PLAN TYPE
  203.   6.30 ITALY MARKET ANALYSIS BY SUM ASSURED
  204.   6.31 ITALY MARKET ANALYSIS BY RIDER OPTIONS
  205.   6.32 SPAIN MARKET ANALYSIS BY PREMIUM RANGE
  206.   6.33 SPAIN MARKET ANALYSIS BY PLAN TYPE
  207.   6.34 SPAIN MARKET ANALYSIS BY SUM ASSURED
  208.   6.35 SPAIN MARKET ANALYSIS BY RIDER OPTIONS
  209.   6.36 REST OF EUROPE MARKET ANALYSIS BY PREMIUM RANGE
  210.   6.37 REST OF EUROPE MARKET ANALYSIS BY PLAN TYPE
  211.   6.38 REST OF EUROPE MARKET ANALYSIS BY SUM ASSURED
  212.   6.39 REST OF EUROPE MARKET ANALYSIS BY RIDER OPTIONS
  213.   6.40 APAC MARKET ANALYSIS
  214.   6.41 CHINA MARKET ANALYSIS BY PREMIUM RANGE
  215.   6.42 CHINA MARKET ANALYSIS BY PLAN TYPE
  216.   6.43 CHINA MARKET ANALYSIS BY SUM ASSURED
  217.   6.44 CHINA MARKET ANALYSIS BY RIDER OPTIONS
  218.   6.45 INDIA MARKET ANALYSIS BY PREMIUM RANGE
  219.   6.46 INDIA MARKET ANALYSIS BY PLAN TYPE
  220.   6.47 INDIA MARKET ANALYSIS BY SUM ASSURED
  221.   6.48 INDIA MARKET ANALYSIS BY RIDER OPTIONS
  222.   6.49 JAPAN MARKET ANALYSIS BY PREMIUM RANGE
  223.   6.50 JAPAN MARKET ANALYSIS BY PLAN TYPE
  224.   6.51 JAPAN MARKET ANALYSIS BY SUM ASSURED
  225.   6.52 JAPAN MARKET ANALYSIS BY RIDER OPTIONS
  226.   6.53 SOUTH KOREA MARKET ANALYSIS BY PREMIUM RANGE
  227.   6.54 SOUTH KOREA MARKET ANALYSIS BY PLAN TYPE
  228.   6.55 SOUTH KOREA MARKET ANALYSIS BY SUM ASSURED
  229.   6.56 SOUTH KOREA MARKET ANALYSIS BY RIDER OPTIONS
  230.   6.57 MALAYSIA MARKET ANALYSIS BY PREMIUM RANGE
  231.   6.58 MALAYSIA MARKET ANALYSIS BY PLAN TYPE
  232.   6.59 MALAYSIA MARKET ANALYSIS BY SUM ASSURED
  233.   6.60 MALAYSIA MARKET ANALYSIS BY RIDER OPTIONS
  234.   6.61 THAILAND MARKET ANALYSIS BY PREMIUM RANGE
  235.   6.62 THAILAND MARKET ANALYSIS BY PLAN TYPE
  236.   6.63 THAILAND MARKET ANALYSIS BY SUM ASSURED
  237.   6.64 THAILAND MARKET ANALYSIS BY RIDER OPTIONS
  238.   6.65 INDONESIA MARKET ANALYSIS BY PREMIUM RANGE
  239.   6.66 INDONESIA MARKET ANALYSIS BY PLAN TYPE
  240.   6.67 INDONESIA MARKET ANALYSIS BY SUM ASSURED
  241.   6.68 INDONESIA MARKET ANALYSIS BY RIDER OPTIONS
  242.   6.69 REST OF APAC MARKET ANALYSIS BY PREMIUM RANGE
  243.   6.70 REST OF APAC MARKET ANALYSIS BY PLAN TYPE
  244.   6.71 REST OF APAC MARKET ANALYSIS BY SUM ASSURED
  245.   6.72 REST OF APAC MARKET ANALYSIS BY RIDER OPTIONS
  246.   6.73 SOUTH AMERICA MARKET ANALYSIS
  247.   6.74 BRAZIL MARKET ANALYSIS BY PREMIUM RANGE
  248.   6.75 BRAZIL MARKET ANALYSIS BY PLAN TYPE
  249.   6.76 BRAZIL MARKET ANALYSIS BY SUM ASSURED
  250.   6.77 BRAZIL MARKET ANALYSIS BY RIDER OPTIONS
  251.   6.78 MEXICO MARKET ANALYSIS BY PREMIUM RANGE
  252.   6.79 MEXICO MARKET ANALYSIS BY PLAN TYPE
  253.   6.80 MEXICO MARKET ANALYSIS BY SUM ASSURED
  254.   6.81 MEXICO MARKET ANALYSIS BY RIDER OPTIONS
  255.   6.82 ARGENTINA MARKET ANALYSIS BY PREMIUM RANGE
  256.   6.83 ARGENTINA MARKET ANALYSIS BY PLAN TYPE
  257.   6.84 ARGENTINA MARKET ANALYSIS BY SUM ASSURED
  258.   6.85 ARGENTINA MARKET ANALYSIS BY RIDER OPTIONS
  259.   6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY PREMIUM RANGE
  260.   6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY PLAN TYPE
  261.   6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY SUM ASSURED
  262.   6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY RIDER OPTIONS
  263.   6.90 MEA MARKET ANALYSIS
  264.   6.91 GCC COUNTRIES MARKET ANALYSIS BY PREMIUM RANGE
  265.   6.92 GCC COUNTRIES MARKET ANALYSIS BY PLAN TYPE
  266.   6.93 GCC COUNTRIES MARKET ANALYSIS BY SUM ASSURED
  267.   6.94 GCC COUNTRIES MARKET ANALYSIS BY RIDER OPTIONS
  268.   6.95 SOUTH AFRICA MARKET ANALYSIS BY PREMIUM RANGE
  269.   6.96 SOUTH AFRICA MARKET ANALYSIS BY PLAN TYPE
  270.   6.97 SOUTH AFRICA MARKET ANALYSIS BY SUM ASSURED
  271.   6.98 SOUTH AFRICA MARKET ANALYSIS BY RIDER OPTIONS
  272.   6.99 REST OF MEA MARKET ANALYSIS BY PREMIUM RANGE
  273.   6.100 REST OF MEA MARKET ANALYSIS BY PLAN TYPE
  274.   6.101 REST OF MEA MARKET ANALYSIS BY SUM ASSURED
  275.   6.102 REST OF MEA MARKET ANALYSIS BY RIDER OPTIONS
  276.   6.103 KEY BUYING CRITERIA OF BFSI
  277.   6.104 RESEARCH PROCESS OF MRFR
  278.   6.105 DRO ANALYSIS OF BFSI
  279.   6.106 DRIVERS IMPACT ANALYSIS: BFSI
  280.   6.107 RESTRAINTS IMPACT ANALYSIS: BFSI
  281.   6.108 SUPPLY / VALUE CHAIN: BFSI
  282.   6.109 BFSI, BY PREMIUM RANGE, 2024 (% SHARE)
  283.   6.110 BFSI, BY PREMIUM RANGE, 2024 TO 2035 (USD Billion)
  284.   6.111 BFSI, BY PLAN TYPE, 2024 (% SHARE)
  285.   6.112 BFSI, BY PLAN TYPE, 2024 TO 2035 (USD Billion)
  286.   6.113 BFSI, BY SUM ASSURED, 2024 (% SHARE)
  287.   6.114 BFSI, BY SUM ASSURED, 2024 TO 2035 (USD Billion)
  288.   6.115 BFSI, BY RIDER OPTIONS, 2024 (% SHARE)
  289.   6.116 BFSI, BY RIDER OPTIONS, 2024 TO 2035 (USD Billion)
  290.   6.117 BENCHMARKING OF MAJOR COMPETITORS
  291. 7 LIST OF TABLES
  292.   7.1 LIST OF ASSUMPTIONS
  293.     7.1.1
  294.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  295.     7.2.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  296.     7.2.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  297.     7.2.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  298.     7.2.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  299.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  300.     7.3.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  301.     7.3.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  302.     7.3.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  303.     7.3.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  304.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  305.     7.4.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  306.     7.4.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  307.     7.4.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  308.     7.4.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  309.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  310.     7.5.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  311.     7.5.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  312.     7.5.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  313.     7.5.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  314.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  315.     7.6.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  316.     7.6.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  317.     7.6.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  318.     7.6.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  319.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  320.     7.7.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  321.     7.7.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  322.     7.7.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  323.     7.7.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  324.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  325.     7.8.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  326.     7.8.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  327.     7.8.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  328.     7.8.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  329.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  330.     7.9.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  331.     7.9.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  332.     7.9.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  333.     7.9.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  334.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  335.     7.10.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  336.     7.10.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  337.     7.10.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  338.     7.10.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  339.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  340.     7.11.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  341.     7.11.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  342.     7.11.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  343.     7.11.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  344.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  345.     7.12.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  346.     7.12.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  347.     7.12.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  348.     7.12.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  349.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  350.     7.13.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  351.     7.13.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  352.     7.13.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  353.     7.13.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  354.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  355.     7.14.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  356.     7.14.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  357.     7.14.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  358.     7.14.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  359.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  360.     7.15.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  361.     7.15.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  362.     7.15.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  363.     7.15.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  364.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  365.     7.16.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  366.     7.16.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  367.     7.16.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  368.     7.16.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  369.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  370.     7.17.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  371.     7.17.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  372.     7.17.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  373.     7.17.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  374.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  375.     7.18.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  376.     7.18.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  377.     7.18.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  378.     7.18.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  379.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  380.     7.19.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  381.     7.19.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  382.     7.19.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  383.     7.19.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  384.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  385.     7.20.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  386.     7.20.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  387.     7.20.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  388.     7.20.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  389.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  390.     7.21.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  391.     7.21.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  392.     7.21.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  393.     7.21.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  394.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  395.     7.22.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  396.     7.22.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  397.     7.22.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  398.     7.22.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  399.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  400.     7.23.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  401.     7.23.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  402.     7.23.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  403.     7.23.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  404.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  405.     7.24.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  406.     7.24.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  407.     7.24.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  408.     7.24.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  409.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  410.     7.25.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  411.     7.25.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  412.     7.25.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  413.     7.25.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  414.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  415.     7.26.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  416.     7.26.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  417.     7.26.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  418.     7.26.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  419.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  420.     7.27.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  421.     7.27.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  422.     7.27.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  423.     7.27.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  424.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  425.     7.28.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  426.     7.28.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  427.     7.28.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  428.     7.28.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  429.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  430.     7.29.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  431.     7.29.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  432.     7.29.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  433.     7.29.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  434.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  435.     7.30.1 BY PREMIUM RANGE, 2025-2035 (USD Billion)
  436.     7.30.2 BY PLAN TYPE, 2025-2035 (USD Billion)
  437.     7.30.3 BY SUM ASSURED, 2025-2035 (USD Billion)
  438.     7.30.4 BY RIDER OPTIONS, 2025-2035 (USD Billion)
  439.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  440.     7.31.1
  441.   7.32 ACQUISITION/PARTNERSHIP
  442.     7.32.1

BFSI Market Segmentation

BFSI By Premium Range (USD Billion, 2025-2035)

  • Low Premium
  • Mid Premium
  • High Premium

BFSI By Plan Type (USD Billion, 2025-2035)

  • Comprehensive Plan
  • Specific Illness Plan
  • Critical Illness Plan

BFSI By Sum Assured (USD Billion, 2025-2035)

  • Up to Rs. 5 lakhs
  • Rs. 5 lakhs to Rs. 10 lakhs
  • Above Rs. 10 lakhs

BFSI By Rider Options (USD Billion, 2025-2035)

  • Maternity Rider
  • Child Rider
  • Hospital Cash Rider

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions